These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26299850)
1. Leflunomide, a Reversible Monoamine Oxidase Inhibitor. Petzer JP; Petzer A Cent Nerv Syst Agents Med Chem; 2016; 16(2):112-9. PubMed ID: 26299850 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents. Agrawal N; Mishra P Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360 [TBL] [Abstract][Full Text] [Related]
3. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase. Mostert S; Petzer A; Petzer JP Eur J Med Chem; 2017 Jul; 135():196-203. PubMed ID: 28456030 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase by benzoxathiolone analogues. Mostert S; Petzer A; Petzer JP Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818 [TBL] [Abstract][Full Text] [Related]
5. Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility. Yoshimi K; Kozuka M; Sakai J; Iizawa T; Shimizu Y; Kaneko I; Kojima K; Iwata N Jpn J Pharmacol; 2002 Feb; 88(2):174-82. PubMed ID: 11928718 [TBL] [Abstract][Full Text] [Related]
6. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Engelbrecht I; Petzer JP; Petzer A Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942 [TBL] [Abstract][Full Text] [Related]
8. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B. Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
10. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework. Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149 [TBL] [Abstract][Full Text] [Related]
11. The interactions of caffeine with monoamine oxidase. Petzer A; Pienaar A; Petzer JP Life Sci; 2013 Aug; 93(7):283-7. PubMed ID: 23850513 [TBL] [Abstract][Full Text] [Related]
12. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase. Engelbrecht I; Petzer JP; Petzer A Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034 [TBL] [Abstract][Full Text] [Related]
13. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B. Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267 [TBL] [Abstract][Full Text] [Related]
19. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B. Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857 [TBL] [Abstract][Full Text] [Related]